Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10521 - 10528 of 12011 results
Is Your HIPAA Compliance Program Going Out the Window with XP?
April 8, 2014| Blog| Viewpoint
HHS Extends Medicare Coverage to Same-Sex Couples
April 7, 2014| Blog| Viewpoint
H-1B Cap Hit for Fiscal Year 2015
April 7, 2014| Alert| Viewpoint
Privacy Monday: April 4, 2014 -- Fandango and Credit Karma and What They Should Mean to Your Mobile App
April 7, 2014| Blog| Viewpoint
The Affordable Care Act—Countdown to Compliance for Employers, Week 38: Congress Eliminates Separate Cap on Deductibles
April 7, 2014| Blog| Viewpoint
How Will ITC Confirmation That It Has Jurisdiction Over Digital Imports Impact Software and Media Industries?
April 4, 2014| Blog| Viewpoint
SEC Enforcement Staff's Investigations of Financially Stressed Municipal Issuers
April 3, 2014| Blog| Viewpoint
Tri-Agency Health IT Report Issued
April 3, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|